Compared with other BC subtypes, HER2-positive cancer subtypes are characterized by decreased apoptosis and enhanced cell proliferation, mobility, adherence, invasiveness, angiogenesis, metastasis, and epithelial cell survival [7]. This evidence concerns the gene ERBB2 and breast cancer.